Epitalon Acetate CAS:307297-40-1

Epithalon was first discovered in the late 1980's by Prof. Vladimir Khavinson from St. Petersburg, Russia. It has been studied extensively ever since. It is known by several names, including Epitalon, Epithalon, Epithalone, Epithalamin and Epithalamine. Since all the patents are held by the Russian inventor there is not much interest for this tetra-peptide from the western big pharma industry. This makes the substance fairly unknown in the west due to the absence of marketing usually seen with big pharma products. In Russia it is currently in clinical studies and shows prospective results as treatment for liver disorders, neuropathology, psychiatry and geriatrics.

Epitalon decrescit mutationes in aevum relatas in systematibus immunibus et neuroendocrinis, reduces incidentes infectiones recurrentes et morbi longi. Longum terminum clinicum tentationum ostendimus Epithalamin in patientibus pathologiae veteris relatas inaequalitatem in systematibus prooxidationis et antioxidationis removere.. Proventus curationi XII mensium cum Epithalon in aegris cum signis maturati senescentis effectum normaliandi ostendit in metabolismo et conditione variarum systematum functionis. Uric acidum elevatum, alkaline phosphatase et cholesterol in senioribus aegris ad normales rediit 10 diebus curatio, et per aliquot menses peroidus postea stabilis permansit.